Event Type
Disclosure
Mandatory
Variant
8-K
. Entry Into or Amendment of a Material Definitive Agreement. On February 19, 2026, Klotho Neurosciences, Inc. (the “Company”) entered into a Securities Purchas
Financial Statements and Exhibits. Exhibits Description 4.1 Form of Warrant 10.1 Securities Purchase Agreement 104 Cover Page Interactive Data File (embedded wi